Journal: Current Cancer Drug Targets Volume: 20 Issue: 6 Year: 2020 Page: 429-460 Author(s): Mohammed Shaaban,Heba Othman,Takwa Ibrahim,Mariam Ali,Mohamed Abdelmoaty,Abdel-Rahman Abdel-Kawi,Ahmed Mostafa,Aya El Nakeeb,Heba Emam,Alaa Refaat
Journal: Current Pharmaceutical Analysis Volume: 5 Issue: 4 Year: 2009 Page: 390-407 Author(s): Michael Adler, Mark Spengler
Journal: Current Pharmaceutical Biotechnology Volume: 12 Issue: 1 Year: 2011 Page: 2150-2157 Author(s): Peter Hau, Piotr Jachimczak, Jurgen Schlaier, Ulrich Bogdahn
Journal: Coronaviruses Volume: 2 Issue: 2 Year: 2021 Page: 255-264 Author(s): Abhishek Sengupta,Pooja Vijayaraghavan,Priyansh Srivastava,Lovely Gupta,Chaitanya Chandwani,Priyanka Narad
Ebook: Frontiers in Cancer Immunology Volume: 2 Year: 2016 Author(s): Mahbuba Rahman Doi: 10.2174/9781681083070116020003
Journal: Infectious Disorders - Drug Targets Volume: 13 Issue: 1 Year: 2013 Page: 34-45 Author(s): Rashmi Dixit,Gulam Khandaker,Scott Ilgoutz,Harunor Rashid,Robert Booy
Journal: Current Stem Cell Research & Therapy Volume: 17 Issue: 4 Year: 2022 Page: 328-338 Author(s): Suman Kumar Ray
Journal: Reviews on Recent Clinical Trials Volume: 3 Issue: 2 Year: 2008 Page: 121-125 Author(s): Angela Marten
Journal: Mini-Reviews in Medicinal Chemistry Volume: 16 Issue: 18 Year: 2016 Page: 1444-1449 Author(s): Bernhard Grubmüller,Morgan Roupret,Alberto Briganti,Shahrokh F. Shariat
Ebook: COVID-19: Origin, Impact and Management, Part 1 Volume: 1 Year: 2023 Author(s): Doi: 10.2174/9789815123883123010004
Previous Next